Labcorp Bull Case
Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:
-
Laboratory Co. of America Holdings recently launched the Thrive 5 Health Test in collaboration with Arianna Huffington's Thrive Global, a development that combines the company's scientific expertise with behavior change technology to help consumers turn health insights into healthier daily habits, potentially expanding its consumer-facing revenue streams.
-
The stock is currently trading at $316.87, which is below the consensus price target of $337.73 set by twelve analysts who have issued reports in the last year, suggesting there is still room for upside potential as the company continues to execute on its growth strategy.
-
Laboratory Co. of America Holdings has demonstrated strong earnings momentum, beating consensus estimates in its most recent quarterly report with an actual EPS of $4.99 compared to the expected $4.78, while also achieving revenue of $3.73 billion, which exceeded the analyst expectation of $3.71 billion.
-
The company has received a "Moderate Buy" consensus rating from analysts, with nine out of twelve covering the stock assigning a "Buy" recommendation, indicating broad institutional confidence in the company's long-term outlook and operational performance.
-
Laboratory Co. of America Holdings has maintained a consistent track record of beating earnings estimates over the last four quarters, with actual EPS exceeding consensus in each period, which reflects strong operational efficiency and the ability to deliver value to shareholders.